Moderate to Severe Chronic Spontaneous Urticaria (CSU) or Moderate to Severe Hidradenitis Suppurativa (HS) research hub

PHASE 2a OPEN-LABEL BASKET STUDY TO EVALUATE SAFETY AND PHARMACOKINETICS OF INF904, AN ORAL C5aR1 INHIBITOR, IN SUBJECTS WITH MODERATE TO SEVERE CHRONIC SPONTANEOUS URTICARIA OR HIDRADENITIS SUPPURATIVA

This study is testing a new medicine called INF904 for people with chronic hives or hidradenitis suppurativa. Researchers want to see if it's safe, how much stays in the body, and if it causes any side effects. It's an early-stage study to learn more about this new treatment.